Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials.
- Published in:
- Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02059-w
- By:
- Publication type:
- Article
Works matching DE "SELECTIVE estrogen receptor modulators"
Results: 1146
1
2
Update in the clinical utilization of chemoprevention for breast cancer: a narrative review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1435253
- By:
- Publication type:
- Article
3
Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2016, v. 42, n. 12, p. 1744, doi. 10.1111/jog.13105
- By:
- Publication type:
- Article
4
Estrogens and lipids.
- Published in:
- Postgraduate Medicine, 2002, v. 111, n. 1, p. 23
- By:
- Publication type:
- Article
5
SERMs and cardiovascular disease in women.
- Published in:
- Postgraduate Medicine, 2001, v. 109, p. 17
- By:
- Publication type:
- Article
6
Effects of estrogen deficiency on brain function.
- Published in:
- Postgraduate Medicine, 2001, v. 109, p. 11
- By:
- Publication type:
- Article
7
Selective estrogen receptor modulators.
- Published in:
- Postgraduate Medicine, 2001, v. 109, p. 3
- By:
- Publication type:
- Article
8
Menopause and mood.
- Published in:
- Postgraduate Medicine, 2000, v. 108, n. 3, p. 34
- By:
- Publication type:
- Article
9
Relative potencies of natural estrogens on vitellogenin and choriogenin levels in the Indian freshwater spotted snakehead, Channa punctata: in vivo and in vitro studies.
- Published in:
- Fish Physiology & Biochemistry, 2010, v. 36, n. 3, p. 587, doi. 10.1007/s10695-009-9332-8
- By:
- Publication type:
- Article
10
2′,3′,4′-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00470-z
- By:
- Publication type:
- Article
11
Raloxifene alleviates amyloid‐β‐induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2019, v. 33, n. 11, p. N.PAG, doi. 10.1002/jbt.22395
- By:
- Publication type:
- Article
12
Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 5, p. 1, doi. 10.1210/jcemcr/luae050
- By:
- Publication type:
- Article
13
Combination of chemotherapy and endocrine treatment in breast cancer -- is it still a taboo?
- Published in:
- Oncology in Clinical Practice (2450-1654), 2024, v. 20, n. 4, p. 302, doi. 10.5603/ocp.100128
- By:
- Publication type:
- Article
14
Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates.
- Published in:
- NPJ Regenerative Medicine, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41536-022-00214-x
- By:
- Publication type:
- Article
15
Accumulation of environmental estrogens in adipose tissue of breast cancer patients.
- Published in:
- Journal of Environmental Science & Health. Part A. Toxic/Hazardous Substances & Environmental Engineering, 2010, v. 45, n. 3, p. 305, doi. 10.1080/10934520903468038
- By:
- Publication type:
- Article
16
Solid State Interaction of Raloxifene HCl with Different Hydrophilic Carriers During Co-grinding and its Effect on Dissolution Rate.
- Published in:
- Drug Development & Industrial Pharmacy, 2009, v. 35, n. 4, p. 455, doi. 10.1080/03639040802438365
- By:
- Publication type:
- Article
17
Dosing Time-Dependent Effect of Raloxifene on Plasma Fibrinogen Concentration in Ovariectomized Rats.
- Published in:
- Chronobiology International: The Journal of Biological & Medical Rhythm Research, 2008, v. 25, n. 5, p. 808, doi. 10.1080/07420520802387682
- By:
- Publication type:
- Article
18
Steroids in aquatic invertebrates.
- Published in:
- Ecotoxicology, 2007, v. 16, n. 1, p. 109, doi. 10.1007/s10646-006-0113-1
- By:
- Publication type:
- Article
19
Sex steroid receptor evolution and signalling in aquatic invertebrates.
- Published in:
- Ecotoxicology, 2007, v. 16, n. 1, p. 131, doi. 10.1007/s10646-006-0111-3
- By:
- Publication type:
- Article
20
Is There a Role for Hormonal Therapy in Men with Oligoasthenoteratozoospermia (OAT)?
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 1, p. 185, doi. 10.3390/jcm14010185
- By:
- Publication type:
- Article
21
Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3611, doi. 10.3390/jcm13123611
- By:
- Publication type:
- Article
22
Estetrol: A New Choice for Contraception.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5625, doi. 10.3390/jcm10235625
- By:
- Publication type:
- Article
23
Elastography of Endometrium in Women Taking Tamoxifen: A New Approach to an Old Diagnostic Problem.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3870, doi. 10.3390/jcm9123870
- By:
- Publication type:
- Article
24
Selective estrogen receptor modulators and deep venous thrombosis after an emergent operation in senior women.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
25
Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 507, doi. 10.1634/theoncologist.2015-0464
- By:
- Publication type:
- Article
26
Empirical Treatments for Male Infertility: A Focus on Lifestyle Modifications and Medicines.
- Published in:
- Diseases, 2024, v. 12, n. 9, p. 209, doi. 10.3390/diseases12090209
- By:
- Publication type:
- Article
27
Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study.
- Published in:
- Antioxidants, 2022, v. 11, n. 11, p. 2204, doi. 10.3390/antiox11112204
- By:
- Publication type:
- Article
28
BMS 33rd annual scientific conference Menopause: solving the puzzle.
- Published in:
- Post Reproductive Health, 2024, v. 30, p. 4S, doi. 10.1177/20533691241284427
- Publication type:
- Article
29
Treatment of menopausal skin – A narrative review of existing treatments, controversies, and future perspectives.
- Published in:
- Post Reproductive Health, 2024, v. 30, n. 2, p. 85, doi. 10.1177/20533691241233440
- By:
- Publication type:
- Article
30
A systematic review of randomised clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors.
- Published in:
- Post Reproductive Health, 2023, v. 29, n. 4, p. 222, doi. 10.1177/20533691231208473
- By:
- Publication type:
- Article
31
BMS consensus statement for primary prevention of coronary heart disease in women.
- Published in:
- 2019
- By:
- Publication type:
- journal article
32
BMS - Consensus statement.
- Published in:
- 2018
- By:
- Publication type:
- journal article
33
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
- Published in:
- 2015
- By:
- Publication type:
- journal article
34
Comparing the effects of low-level laser therapy and gaseous ozone as a preventive measure on medication-related osteonecrosis of the jaws following tooth extraction: a rat model.
- Published in:
- European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-01907-3
- By:
- Publication type:
- Article
35
Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-89915-z
- By:
- Publication type:
- Article
36
Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 623, doi. 10.1002/cpdd.1062
- By:
- Publication type:
- Article
37
ACCP Abstract Booklet.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, p. 1, doi. 10.1002/cpdd.1004
- Publication type:
- Article
38
A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 8, p. 911, doi. 10.1002/cpdd.458
- By:
- Publication type:
- Article
39
Population Pharmacokinetic/ Pharmacodynamic Assessment of Pharmacological Effect of a Selective Estrogen Receptor β Agonist on Total Testosterone in Healthy Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 305, doi. 10.1002/cpdd.184
- By:
- Publication type:
- Article
40
A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 262, doi. 10.1002/cpdd.102
- By:
- Publication type:
- Article
41
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives.
- Published in:
- Obesity Reviews, 2022, v. 23, n. 2, p. 1, doi. 10.1111/obr.13358
- By:
- Publication type:
- Article
42
Prevention of corticosteroid-induced osteoporosis and fractures.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 1999, v. 24, n. 2, p. 83, doi. 10.1046/j.1365-2710.1999.00209.x
- By:
- Publication type:
- Article
43
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00359
- By:
- Publication type:
- Article
44
Selective oestrogen receptor modulators: potential therapeutic applications.
- Published in:
- Clinical Endocrinology, 1998, v. 48, n. 4, p. 389, doi. 10.1046/j.1365-2265.1998.00468.x
- By:
- Publication type:
- Article
45
Response To: "Bisphosphonates Related Ocular Side Effects: A Case Series and Review of Literature".
- Published in:
- Ocular Immunology & Inflammation, 2022, v. 30, n. 7/8, p. 2072, doi. 10.1080/09273948.2021.1936567
- By:
- Publication type:
- Article
46
Pulmonary Embolism as a Rare Complication of Clomiphene Therapy: A Case Report and Literature Review.
- Published in:
- Case Reports in Endocrinology, 2021, p. 1, doi. 10.1155/2021/9987830
- By:
- Publication type:
- Article
47
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
- Published in:
- British Journal of Pharmacology, 2007, v. 151, n. 3, p. 384, doi. 10.1038/sj.bjp.0707232
- By:
- Publication type:
- Article
48
Biological activities of a novel selective oestrogen receptor modulator derived from raloxifene (Y134).
- Published in:
- British Journal of Pharmacology, 2007, v. 150, n. 1, p. 19, doi. 10.1038/sj.bjp.0706960
- By:
- Publication type:
- Article
49
Beyond raloxifene for the prevention of osteoporosis and breast cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
50
Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.
- Published in:
- British Journal of Pharmacology, 2006, v. 147, n. 5, p. 542, doi. 10.1038/sj.bjp.0706640
- By:
- Publication type:
- Article